Table 4.

Survival (in days) of the trial patients and reported MRI responses.

Patient	Dose (vp)	Response type	Survival in days
1	107		169
2	107	Survival	280
3	107	Survival	225
4	108		86
5	108		98
6	108		129
7	109	MRI	96
8	109		94
9	109		96
10	1010	Survival	211
11	1010	MRI	106
12	1010		131
13	3 × 1010		95
14	Not infused
15	3 × 1010	MRI + survival	2,792a
16	1010	MRI + survival	976
17	1010		82
18	1010		146
19	1010		68
20	1010	Survival	199

^aPatient currently alive 7.5 years after initial Delta24-RGD treatment.